These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15813826)

  • 1. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
    Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
    J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs].
    Ahlbach S; Usadel KH; Kaufmann R; Boehncke WH
    Med Klin (Munich); 2003 Apr; 98(5):242-4. PubMed ID: 12721666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib, safe in NSAID intolerance.
    García-Rodríguez RM; Hinojosa M; Camacho-Garrido E; Berges Gimeno P; Martín García C
    Allergy; 2002 Nov; 57(11):1085-6. PubMed ID: 12359017
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse dermatological reactions to pyrazolones.
    Voigtländer V
    Agents Actions Suppl; 1986; 19():303-11. PubMed ID: 3489359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urticaria--angioedema induced by non-steroidal anti-inflammatory analgesics].
    Díez Gómez ML; Alvarez Cuesta E; Hinojosa Macías M; García Cañadillas F; Alcover Sánchez R
    Allergol Immunopathol (Madr); 1984; 12(3):179-88. PubMed ID: 6332509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan].
    Moriya M; Aihara M; Hirota R; Hirata Y; Ikinaga N; Takamura N; Kunimi Y; Uchida T; Ikezawa Z
    Arerugi; 2011 Jun; 60(6):699-707. PubMed ID: 21709437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs.
    Liccardi G; Cazzola M; De Giglio C; Manfredi D; Piscitelli E; D'Amato M; D'Amato G
    J Investig Allergol Clin Immunol; 2005; 15(4):249-53. PubMed ID: 16433205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs.
    Giuseppe P; Antonino R; Alessandro DB; Donato Q; Marina DF; Donatella P; Francesca G; Alberto V
    Ann Allergy Asthma Immunol; 1997 Jan; 78(1):74-8. PubMed ID: 9012626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and paracetamol tolerance in patients with nimesulide-induced urticaria.
    Asero R
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):237-8. PubMed ID: 9759800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)].
    Boehncke S; Boehncke WH
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2249-52. PubMed ID: 16208597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.
    Mastalerz L; Sanak M; Gawlewicz A; Gielicz A; Faber J; Szczeklik A
    J Allergy Clin Immunol; 2006 Oct; 118(4):957-8. PubMed ID: 17030252
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions postal survey-bronchial asthma and angioedema with nimesulide.
    Mangalvedhekar SS; Gogtay NJ; Phadke AV; Gore S; Shah JM; Shah SM; Kshirsagar NA
    J Assoc Physicians India; 2000 May; 48(5):548. PubMed ID: 11273160
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema.
    Colanardi MC; Nettis E; Traetta P; Daprile C; Fitto C; Aloia AM; Di Leo E; Ferrannini A; Vacca A
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):82-5. PubMed ID: 18254487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of nimesulide in NSAID intolerant patients.
    Valero Santiago A; González-Morales MA; Martí Guadaño E;
    Allergy; 2003 Apr; 58(4):367-8. PubMed ID: 12708990
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of short-term administration of celecoxib in decompensated cirrhosis.
    Campbell MS; Makar GA
    Hepatology; 2005 Jul; 42(1):237; author reply 238. PubMed ID: 15892075
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerability of nimesulide in aspirin-sensitive patients.
    Andri L; Senna G; Betteli C; Givanni S; Scaricabarozzi I; Mezzelani P; Andri G
    Ann Allergy; 1994 Jan; 72(1):29-32. PubMed ID: 8291746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
    Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.